29. 8. 2007 » 31. 8. 2007 2nd International Conference of Neurons and Brain Disease More information at www e-mail: info@biomedcentral.comtel.: +44 (0)20 7323 0323www: www.biomedcentral.com/info/update
10. March 2026 From essential medicine to illicit commodity: new EU report reveals how ketamine diversion is fuelling the illicit market in Europe Ketamine produced legitimately outside the EU to make medicines is increasingly finding its way onto Europe’s illicit drug...